Work

High-Entropy Alloys for Biomedical Applications: A Comprehensive Review

Year: 2026
Type: article
Abstract: High-entropy alloys (HEAs) represent a paradigmatic shift in metallic biomaterial design, offering unprecedented compositional flexibility for biomedical applications. This comprehensive review examines the current state and future prospects of biocompatible HEAs, focusing on their unique advantages over conventional biomedical alloys. Biocompatible HEAs (Bio-HEAs), primarily composed of non-toxic elements such as Ti, Zr, Hf, Nb, and Ta, demonstrate superior biocompatibility, tunable mechanical properties, and enhanced corrosion resistance. Recent advances in additive manufacturing have enabled complex geometries and microstructural control while maintaining excellent mechanical properties with elastic moduli ranging from 50-80 GPa, closely matching bone properties. Current biocompatibility studies show promising in vitro results with high cell viability (>80%) and excellent osseointegration potential. Manufacturing challenges remain, including high processing costs and limited long-term clinical data. The global HEA market, valued at $67 million in 2023, is projected to reach $316.1 million by 2030, with biomedical applications driving significant growth. This review provides a roadmap for future research, emphasizing the need for standardized testing protocols, cost-effective manufacturing routes, and comprehensive clinical validation to realize the full potential of Bio-HEAs in next-generation medical devices.
Language: English
Open Access status: diamond
OpenAlex ID: W7220031059
FWCI:
Cites: 97
Cited by:
Related to: 10